News
Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
1don MSN
There are significant questions on how the order can be implemented, and if companies can raise prices on already approved ...
Drugmakers' shares fell globally after President Trump said he would [sign an executive order]( ...
Shares of pharmaceutical companies dropped early Monday after President Donald Trump said he would lower the cost of ...
Evaluate AbbVie Inc. vs. Pfizer Inc. amidst tariff disputes and drug pricing policies. Click for our comparison of ABBV and ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are ...
Income investors have liked Pfizer (NYSE: PFE) for years. However, the big drugmaker's exceptionally juicy dividend these ...
We recently published a list of the 15 Best High-Yield Dividend Stocks for 2025 and Beyond. In this article, we are going to ...
5d
24/7 Wall St. on MSNPfizer (NYSE:PFE) Hasn't Been This Cheap in 13 Years. Time to Buy?Pfizer (NYSE:PFE) is one of the world’s largest pharmaceutical companies, but at $22.59 per share as of this writing, the ...
Investing.com -- Moody’s Ratings has assigned an A2 rating to Pfizer Netherlands International Finance B.V. (PNIF BV), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results